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Results of the Study
GROUP 1 (SEC
NEFGATIVE)
(n=97)
GROUP 2 (SEC
POSITIVE)
(n=75) P value
Basal demographic and clinical features
Age, (years) 61.90  15.75 67.82  10.23 0.05
Male, n (%) 70 (72.2%) 35 (46.7%) 0.001
Heart rate, (bpm) 88.90  20.95 91.84  20.51 0.360
SBP, (mmHg) 126.55  20.79 129.05  18.46 0.414
DBP, (mmHg) 76.24  13.11 76.04  13.69 0.920
CAD, n (%) 30 (30.9%) 24 (32%) 0.881
HT, n (%) 47 (48.5%) 35 (46.7%) 0.816
HL, n (%) 20 (20.6%) 15 (20%) 0.920
DM, n (%) 27 (27.8%) 21 (28%) 0.981
Laboratory ﬁndings
Glucose, (mg/dl) 119.92  55.52 110.37  28.82 0.177
GFR, (mL/min) 71.83  21.81 64.18  24.29 0.031
LDL-C, (mg/dl) 114.23  31.77 110.11  35.27 0.447
WBC,(10.e3/microL) 7388.75  2808.06 7731.04  2264.88 0.390
HB, (g/dL) 13.33  1.98 13.41  1.69 0.779
HCT, (%) 39.96  5.62 41.08  7.28 0.258
PLT, (10.e3/microL) 238.32  77.30 247.49  77.15 0.441
PCT, (%) 0.196  0.06 0.217  0.07 0.058
MPV, (fL) 8.52  1.15 8.94  0.98 0.012
PDW, (%) 16.35  5.32 16.15  2.85 0.764
RDW, (%) 15.16  3.47 15.50  3.51 0.531
Neutrophil/Lmphocyte Ratio 3.16  2.53 3.41  2.45 0.522
Echocardiographic ﬁndings
LVIDd, (mm) 49.72  5.96 50.73  4.88 0.235
LA, (mm) 43.57  7.01 45.62  6.32 0.051
LVEF, (%) 56.79  10.53 55.61  11.12 0.480
Blood ﬂow velocity of LAA (cm/sn) 42.42  15.11 28.84  10.55 < 0.001
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Objectıve: The risk for thromboembolic events in the setting of atrial ﬁbrillation (AF)
begins with deterioration of left atrium mechanical function that is reﬂected by
development of spontaneous echo contrast (SEC). Although left atrium SEC has been
associated with a hypercoagulable state in patients with AF, the precise underlying
pathogenic mechanism behind the SEC is complex and poorly understood. The aim of
the present study is to characterize the clinical, laboratory and echocardiographic
ﬁndings of left atrial SEC.
Materıal-Methods: One hundred seventy two patients with AF in whom trans-
esophageal echocardiography was performed were enrolled to this study. Patients were
categorized according to the presence of the left atrial SEC. Group 1 was consisted of
patientswith AF and left atrial SEC (-), and group 2was consisted of patients with AF and
left atrial SEC (+). Basal demographic, laboratory and echocardiographic features of the
patientswere compared between two groups. Statistical analyses (Independent-Samples T
test and Chi-Square tests) were used to evaluate the differences between two groups.
Results: The study group was consisted of 105men (61%) and 67women (39%), and the
mean age of total patients was 64.48 13.90 years. Group 1 was consisted of 95 patientsJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POST(70 (72.2%)men,mean age 61.90 15.75 years) andGroup 2was consisted of 72 patients
(35 (46.7%) men and mean age 67.82  10.23 years). In terms of baseline demographic
characteristics, older andmale patientswithAFwere tend to have SEC in the left atrium (p
value0.05 for age, and 0.001 formale sex).Whenwe evaluated the laboratoryﬁndings,we
observed that there are statistically signiﬁcant differences for GFR and MPV values
between twogroups.SEC (+)patients had lowGFRvalues (64.18 24.29mg/dl vs. 71.83
 21.81mg/dl, p value 0.031) and higherMPVvalues (8.94 0.98 fL vs. 8.52 1.15 fL,
p value 0.012) compared with SEC (-) patients. For the echocardiographic ﬁndings,
although SEC (+) patients had large left atrium size and low left ventricular ejection
fraction, there is no a statistically signiﬁcant difference. Furthermore, peak blood ﬂow
velocity of LAA was statistically lower in SEC (+) patients compared with SEC (-) ones
(28.84  10.55 cm/sn vs. 42.42  15.11 cm/sn, p value <0.001).
Conclusıon:We found that older age, male sex, low GFR value, higher MPV value and
low blood ﬂow velocity of LAA were in association with left atrial SEC. These
mentioned patient characteristics may represent a propensity to the risk of thrombo-
embolism in the setting of left atrial SEC, and would be helpful for the better recognition
and/or managing of ongoing pathologies due to the future thromboembolic events in
patients with AF. Further prospective studies are required to identify the prognostic
signiﬁcance these risk factors in the pathogenesis of left atrial SEC in patients with AF.PP-138
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Background: TheA1298C allele is characterized by a pointmutation at position 1298 of
the methyleletetrahydrofolate reductase (MTHFR) gene causing the replacement of
glutamine by alanine in the corresponding enzyme. MTHFR gene A1298C mutation is
associated with moderately elevated homocysteine levels. Mutations in genes of the
homocysteinemetabolic pathwaymay confer an increased risk for ischemic stroke related
to elevated plasma homocysteine levels. MTHFR polymorphism has been proposed by
some studies to be also a thrombophilic risk factor for thrombosis.Atrialﬁbrillation (AF) is
the commonest sustained cardiac arrhythmia, which confers a high risk of mortality and
morbidity from stroke and thromboembolism.We aimed to investigateMTHFR A1298C
mutation in patients with AF who have had a stroke than in healthy controls.
Methods: MTHFR gene A1298C mutation was analysed in 70 patients with non-
valvuler AF who have had a stroke and 70 healthy individuals with no documented
episode of AF matched for age, race and sex. After DNA isolation, polymorphisms
were analyze using Polymerase Chain Reaction-Restriction Fragment Length Poly-
morphism methods. 1298 AA genotype is the "normal" homozygous, 1298 AC
genotype the heterozygous, and 1298 CC genotype the homozygous for the "variant".ERS C135
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SResults: There was no signiﬁcant difference with respect to age and gender between
groups. The genotype distribution in nonvalvuler AF who have had a stroke group was
as follows: normal genotype (AA) frequency was 39 (55.7%), heterozygous mutant
genotype (AC) frequency was 27 (38.6%) and homozygous mutant genotype (CC)
frequency was 4 (5.7%). The genotype distribution in control group was as follows:
normal genotype (AA) frequency was 42 (60%), heterozygous genotype (AC)
frequency was 26 (37.1%) and homozygous mutant genotype (CC) frequency was 2
(2.9%). There was no statistical difference in genotype distribution among the groups.
Conclusıons: Our results suggest that the MTHFR gene A1298C mutation appears
not to be associated with nonvalvular AF with ischemic stroke in Turkish population.
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Background: Increased serum gamma-glutamyl transpherase levels (GGT) has been
shown to directly promote oxidative stress. In previous studies has been shown the
relationship between the dilatation of the ascending aorta with oxidative stress. This
study was designed to examine the relationship between serum GGT concentrations
with dilatation of the ascending aorta.
Methods: 83 patients with ascending aorta dilatation and 82 healthy person matched
of age and sex were included in the study. The patients were evaluated by a complete
transthoracic echocardiographic examination including measurement of the aortic
dimensions. 4 cm and above ascending aorta dilatation was accepted. Serum GGT
concentration were measured in all patients.
Results: 66 % of 83 patients with ascending aorta dilatation were male and average
age were 5612.1. In the control group 63% of 82 healthy person were male and
average age were 5511.3. In the group of ascending aorta dilatation; tension, left
ventricular mass index, left atrial volume index, serum GGT, serum üric acid, hs- CRP
were found to be signiﬁcantly higher than control group. According to multiple
logistic regression; hypertension history (OR:1.22, 95%CI 1.12-1.32, p<0.05), serum
GGT (OR:1.09, 95%CI 1.04-1.14, p<0.05) for ascending aorta dilatation were found
to be independent variables.
Conclusıons: In conclusion, we found that serum GGT concentration was signiﬁ-
cantly associated with aortic dilatation. The higher serum GGT concentration may be
responsible for the elevated serum antioxidant capacity that was observed among
patients with ascending aorta dilatation. Large epidemiological studies are required to
correlate the ﬁndings from this study with clinical outcome.
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Objectıve: Hemoglobin concentration (Hb) and left ventricular ejection fraction
(LVEF) are known predictors of contrast induced nephropathy (CIN). We hypothe-
sized that product of hemoglobin concentration and left ventricular ejection fraction is
superior to either variable alone in predicting contrast induced nephropathy in patients
with acute coronary syndrome (ACS).
Methods: Consecutive patients with ACS were prospectively enrolled for this study.
Those patients considered for invasive strategy were included. Baseline creatinine
levels were detected on admission and 24, 48 and 72 hours after coronary intervention.
25% or 0,5 mg/dl increase in creatinine level was considered as CIN.
Results: 268 patients with ACS (mean age 5811 years, 77% male) were included in the
study. Contrast induced nephropathy was observed in 26 (9.7%) of patients. Baseline
creatinine concentration, LVEF, Hb and high density lipoprotein cholesterol was signiﬁ-
cantly different between two groups. Contrast volume to estimated glomerular ﬁltration rate
ratio (odds ratio 1.310,95% conﬁdence interval 1.077-1.593, p¼0.007) and the product of
Hb and LVEF (odds ratio 0.996,95% conﬁdence interval 0.994-0.998, p¼0.001) were
found to be independent predictors of contrast induced nephropathy in multivariate
logistic regression analysis. Hb x LVEF < 690 had 85% sensitivity and 57% speciﬁcity
to predict CIN (area under curve: 0.724, 95% conﬁdence interval 0.625-0.824, p<0.001).
In addition, Hb x LVEF < 690 had a negative predictive value of 97 % in our analysis.
Conclusıon: In patients with acute coronary syndrome, the product of hemoglobin
and ejection fraction is better than either variable alone at predicting contrast induced
nephropathy. It predicts contrast induced nephropathy independent of baseline renal
function and volume of contrast agent.C136 JACC VoPP-141
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Purpose: Psoriasis vulgaris is one of the most common skin disorders. Patients with
psoriasis carry an excessive risk of coronary artery disease. Visceral adipose tissue
around the heart affects the heart and coronaries by secreting proatherogenic media-
tors. It could be easily evaluated by measurement of epicardial fat thickness (EFT).
The aim of this study is to investigate EFT in patients with psoriasis vulgaris.
Methods: One hundred and ﬁfteen adult patients with psoriasis vulgaris (group 1) and
60 age- and sex-matched healthy individuals (group 2) were included in this study.
EFT was obtained by transthoracic echocardiography. Disease speciﬁc characteristics
of the patients were recorded. Serum glucose, lipid proﬁle, and high sensitive C-
reactive protein (hsCRP) levels were measured.
Results: EFT andhsCRPwere signiﬁcantly higher in group 1 than in group 2 (5.71.2 vs.
4.11.0 mm, p<0.001 and 0.520.45 mg/dL vs 0.190.17 mg/dL, p<0.001; respec-
tively) (Fig. 1). In patientswith psoriasis vulgaris, EFTwas correlatedwith disease severity
assessed with psoriasis activity score index (PASI)(Fig. 2). The PASI score and hsCRP
were found to be independent predictors of EFT in patients with psoriasis vulgaris
(b¼0.21, t¼2.67, p¼0.01 and b¼0.62, t¼7.72, p¼0.001; respectively).
Conclusıons: Our ﬁndings indicate that EFT was signiﬁcantly higher in patients with
psoriasis vulgaris compared with the controls. It was more prominent in patients with
severe disease.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
